Clinical Trial Update: Propranolol Adjuvant Treatment of Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on propranolol as adjuvant treatment for bladder cancer is in early-stage development with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Central South University | Conditions: Bladder Cancer | Phase 2 | Status: UNKNOWN